Biblio Discovery — Demo Discovery Service

11 results for "Luca Franceschini"

Showing 1–11 · 7.90 seconds · RSS

  1. Journal Article Full text

    Structural Resolution for Abstract Compilation of Object-Oriented Languages

    Luca Franceschini; Davide Ancona; Ekaterina Komendantskaya

    Electronic Proceedings in Theoretical Computer Science, Vol. 258 No. Proc. CoALP-Ty 2016 · 2017 · English · DOAJ

    We propose abstract compilation for precise static type analysis of object-oriented languages based on coinductive logic programming. Source code is translated to a logic program, then type-checking and inference problems amount to queries to be solved with respect to the resulting logic program…

  2. Journal Article Full text

    Towards Runtime Monitoring of Node.js and Its Application to the Internet of Things

    Davide Ancona; Luca Franceschini; Giorgio Delzanno et al.

    Electronic Proceedings in Theoretical Computer Science, Vol. 264 No. Proc. ALP4IoT 2017 · 2018 · English · DOAJ

    In the last years Node.js has emerged as a framework particularly suitable for implementing lightweight IoT applications, thanks to its underlying asynchronous event-driven, non blocking I/O model. However, verifying the correctness of programs with asynchronous nested callbacks is quite difficult…

  3. Journal Article

    Recurrent Sweet's syndrome in a patient with multiple myeloma

    Carmelo Gurnari; Luca Franceschini; Lucia Anemona et al.

    Clinical Case Reports, Vol. 6 No. 10 · 2018 · English · DOAJ Dropped by Scopus 2021

    Key Clinical Message We report on a case of Sweet's syndrome associated with multiple myeloma, as harbinger for disease relapse.

  4. Journal Article Full text

    Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients

    Ombretta Annibali; Livia Piccioni; Valeria Tomarchio et al.

    PLOS ONE, Vol. 13 No. 7 · 2018 · English · PLOS Scopus

    Cytomegalovirus (CMV) infection represents one of the main cause mortality after Stem Cell Transplantation. Recently, a protective effect of the T allele of rs12979860 IL28B Single Nucleotide Polymorphisms (SNPs) against CMV infection in the allogenic stem cell transplantation was suggested. We…

    Also available at: DOAJ

  5. Journal Article

    New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia

    Zaira Ianniello; Melissa Sorci; Lavinia Ceci Ginistrelli et al.

    Cell Death and Disease, Vol. 12 No. 10 · 2021 · English · DOAJ Scopus

    Abstract Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the presence of tyrosine kinase BCR-ABL1 fusion protein, which deregulate transcription and mRNA translation. Tyrosine kinase inhibitors (TKIs) are the first-choice treatment. However, resistance to TKIs remains a…

  6. Journal Article

    A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation

    Massimo R. Mannarino; Vanessa Bianconi; Giulia Scalisi et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    BackgroundChronic systemic inflammation reduces the bioavailability of circulating endothelial progenitor cells (EPCs). Indoleamine 2,3-dioxygenase 1 (IDO1), a key enzyme of immune tolerance catalyzing the initial step of tryptophan degradation along the so-called l-kynurenine (l-kyn) pathway, that…

  7. Journal Article

    Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group

    Francesca Fazio; Luca Franceschini; Valeria Tomarchio et al.

    eJHaem, Vol. 3 No. 1 · 2022 · English · DOAJ

    Abstract The multiple myeloma (MM) treatment has changed over the last years due to the introduction of novel drugs. Despite improvements in the MM outcome, MM remains an incurable disease. Daratumumab is a human IgGK monoclonal antibody targeting CD38 with tumor activity associated with…

  8. Journal Article

    Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation

    Simona Bernardi; Michele Malagola; Camilla Zanaglio et al.

    Cancer Medicine, Vol. 8 No. 5 · 2019 · English · DOAJ Scopus

    Abstract Treatment‐free remission (TFR) by tyrosine kinase inhibitors (TKI) discontinuation in patients with deep molecular response (DMR) is a paramount goal in the current chronic myeloid leukemia (CML) therapeutic strategy. The best DMR level by real‐time quantitative PCR (RT‐qPCR) for TKI…

  9. Journal Article

    Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials

    Sara Bringhen; Maria Victoria Mateos; Sonja Zweegman et al.

    Haematologica, Vol. 98 No. 6 · 2013 · English · DOAJ Scopus

    Thalidomide and bortezomib are extensively used to treat elderly myeloma patients. In these patients, treatment-related side effects are frequent and full drug doses difficult to tolerate. We retrospectively analyzed data from 1435 elderly patients enrolled in 4 European phase III trials including…